Post-translational modifications and correct subcellular localization of viral structural proteins are prerequisites for assembly and budding of enveloped viruses. Coronaviruses, like the severe acute respiratory syndrome-associated virus (SARS-CoV), bud from the endoplasmic reticulum-Golgi intermediate compartment. In this study, the subcellular distribution and maturation of SARS-CoV surface proteins S, M and E were analysed by using C-terminally tagged proteins. As early as 30 min post-entry into the endoplasmic reticulum, high-mannosylated S assembles into trimers prior to acquisition of complex N-glycans in the Golgi. Like S, M acquires high-mannose N-glycans that are subsequently modified into complex N-glycans in the Golgi. The N-glycosylation profile and the absence of O-glycosylation on M protein relate SARS-CoV to the previously described group 1 and 3 coronaviruses. Immunofluorescence analysis shows that S is detected in several compartments along the secretory pathway from the endoplasmic reticulum to the plasma membrane while M predominantly localizes in the Golgi, where it accumulates, and in trafficking vesicles. The E protein is not glycosylated. Pulse-chase labelling and confocal microscopy in the presence of protein translation inhibitor cycloheximide revealed that the E protein has a short half-life of 30 min. E protein is found in bright perinuclear patches colocalizing with endoplasmic reticulum markers. In conclusion, SARS-CoV surface proteins S, M and E show differential subcellular localizations when expressed alone suggesting that additional cellular or viral factors might be required for coordinated trafficking to the virus assembly site in the endoplasmic reticulum-Golgi intermediate compartment.
AppenzellerC.,
AnderssonH.,
KappelerF.,
HauriH. P.1999; The lectin ERGIC-53 is a cargo transport receptor for glycoproteins. Nat Cell Biol 1:330–334[CrossRef]
BaudouxP.,
CarratC.,
BesnardeauL.,
CharleyB.,
LaudeH.1998a; Coronavirus pseudoparticles formed with recombinant M and E proteins induce alpha interferon synthesis by leukocytes. J Virol 72:8636–8643
BosE. C.,
LuytjesW.,
van der MeulenH. V.,
KoertenH. K.,
SpaanW. J.1996; The production of recombinant infectious DI-particles of a murine coronavirus in the absence of helper virus. Virology 218:52–60[CrossRef]
BoschB. J.,
van der ZeeR.,
de HaanC. A.,
RottierP. J.2003; The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol 77:8801–8811[CrossRef]
BuchholzU. J.,
BukreyevA.,
YangL.,
LamirandeE. W.,
MurphyB. R.,
SubbaraoK.,
CollinsP. L.2004; Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity. Proc Natl Acad Sci U S A 101:9804–9809[CrossRef]
BukreyevA.,
LamirandeE. W.,
BuchholzU. J.,
VogelL. N.,
ElkinsW. R.,
St ClaireM.,
MurphyB. R.,
SubbaraoK.,
CollinsP. L.2004; Mucosal immunisation of African green monkeys ( Cercopithecus aethiops ) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS. Lancet 363:2122–2127[CrossRef]
CorseE.,
MachamerC. E.2000; Infectious bronchitis virus E protein is targeted to the Golgi complex and directs release of virus-like particles. J Virol 74:4319–4326[CrossRef]
CorseE.,
MachamerC. E.2003; The cytoplasmic tails of infectious bronchitis virus E and M proteins mediate their interaction. Virology 312:25–34[CrossRef]
de HaanC. A.,
SmeetsM.,
VernooijF.,
VennemaH.,
RottierP. J.1999; Mapping of the coronavirus membrane protein domains involved in interaction with the spike protein. J Virol 73:7441–7452
de HaanC. A.,
VennemaH.,
RottierP. J.2000; Assembly of the coronavirus envelope: homotypic interactions between the M proteins. J Virol 74:4967–4978[CrossRef]
de HaanC. A.,
de WitM.,
KuoL.,
Montalto-MorrisonC.,
HaagmansB. L.,
WeissS. R.,
MastersP. S.,
RottierP. J.2003; The glycosylation status of the murine hepatitis coronavirus M protein affects the interferogenic capacity of the virus in vitro and its ability to replicate in the liver but not the brain. Virology 312:395–406[CrossRef]
de HaanC. A.,
StadlerK.,
GodekeG. J.,
BoschB. J.,
RottierP. J.2004; Cleavage inhibition of the murine coronavirus spike protein by a furin-like enzyme affects cell-cell but not virus-cell fusion. J Virol 78:6048–6054[CrossRef]
DelmasB.,
GelfiJ.,
L'HaridonR.,
VogelL. K.,
SjostromH.,
NorenO.,
LaudeH.1992; Aminopeptidase N is a major receptor for the entero-pathogenic coronavirus TGEV. Nature 357:417–420[CrossRef]
de VriesA. A.,
RaamsmanM. J.,
van DijkH. A.,
HorzinekM. C.,
RottierP. J.1995; The small envelope glycoprotein (GS) of equine arteritis virus folds into three distinct monomers and a disulfide-linked dimer. J Virol 69:3441–3448
EscorsD.,
OrtegoJ.,
EnjuanesL.2001a; The membrane M protein of the transmissible gastroenteritis coronavirus binds to the internal core through the carboxy-terminus. Adv Exp Med Biol 494:589–593
EscorsD.,
CamafeitaE.,
OrtegoJ.,
LaudeH.,
EnjuanesL.2001b; Organization of two transmissible gastroenteritis coronavirus membrane protein topologies within the virion and core. J Virol 75:12228–12240[CrossRef]
FischerF.,
StegenC. F.,
MastersP. S.,
SamsonoffW. A.1998; Analysis of constructed E gene mutants of mouse hepatitis virus confirms a pivotal role for E protein in coronavirus assembly. J Virol 72:7885–7894
GodetM.,
L'HaridonR.,
VautherotJ. F.,
LaudeH.1992; TGEV corona virus ORF4 encodes a membrane protein that is incorporated into virions. Virology 188:666–675[CrossRef]
HofmannH.,
GeierM.,
MarziA.,
KrumbiegelM.,
PeippM.,
FeyG. H.,
GrambergT.,
PohlmannS.2004a; Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor. Biochem Biophys Res Commun 319:1216–1221[CrossRef]
HofmannH.,
HattermannK.,
MarziA.7 other authors2004b; S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients. J Virol 78:6134–6142[CrossRef]
KlumpermanJ.,
LockerJ. K.,
MeijerA.,
HorzinekM. C.,
GeuzeH. J.,
RottierP. J.1994; Coronavirus M proteins accumulate in the Golgi complex beyond the site of virion budding. J Virol 68:6523–6534
KrokhinO.,
LiY.,
AndonovA.13 other authors2003; Mass spectrometric characterization of proteins from the SARS virus: a preliminary report. Mol Cell Proteomics 2:346–356
KuikenT.,
FouchierR. A.,
SchuttenM.19 other authors2003; Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 362:263–270[CrossRef]
LiW.,
MooreM. J.,
VasilievaN.9 other authors2003; Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426:450–454[CrossRef]
LiljestromP.,
GaroffH.1991; A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Biotechnology (N Y) 9:1356–1361[CrossRef]
LimK. P.,
LiuD. X.2001; The missing link in coronavirus assembly. Retention of the avian coronavirus infectious bronchitis virus envelope protein in the pre-Golgi compartments and physical interaction between the envelope and membrane proteins. J Biol Chem 276:17515–17523[CrossRef]
LinG.,
SimmonsG.,
PohlmannS.8 other authors2003; Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR. J Virol 77:1337–1346[CrossRef]
LockerJ. K.,
RoseJ. K.,
HorzinekM. C.,
RottierP. J.1992; Membrane assembly of the triple-spanning coronavirus M protein. Individual transmembrane domains show preferred orientation. J Biol Chem 267:21911–21918
LockerJ. K.,
KlumpermanJ.,
OorschotV.,
HorzinekM. C.,
GeuzeH. J.,
RottierP. J.1994; The cytoplasmic tail of mouse hepatitis virus M protein is essential but not sufficient for its retention in the Golgi complex. J Biol Chem 269:28263–28269
LockerJ. K.,
OpsteltenD. J.,
EricssonM.,
HorzinekM. C.,
RottierP. J.1995; Oligomerization of a trans -Golgi/ trans -Golgi network retained protein occurs in the Golgi complex and may be part of its retention. J Biol Chem 270:8815–8821[CrossRef]
LozachP. Y.,
Lortat-JacobH.,
de Lacroix de LavaletteA.9 other authors2003; DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2. J Biol Chem 278:20358–20366[CrossRef]
LuoZ.,
MatthewsA. M.,
WeissS. R.1999; Amino acid substitutions within the leucine zipper domain of the murine coronavirus spike protein cause defects in oligomerization and the ability to induce cell-to-cell fusion. J Virol 73:8152–8159
MachamerC. E.,
MentoneS. A.,
RoseJ. K.,
FarquharM. G.1990; The E1 glycoprotein of an avian coronavirus is targeted to the cis Golgi complex. Proc Natl Acad Sci U S A 87:6944–6948[CrossRef]
MachamerC. E.,
GrimM. G.,
EsquelaA.,
ChungS. W.,
RollsM.,
RyanK.,
SwiftA. M.1993; Retention of a cis Golgi protein requires polar residues on one face of a predicted α -helix in the transmembrane domain. Mol Biol Cell 4:695–704[CrossRef]
NiemannH.,
GeyerR.,
KlenkH. D.,
LinderD.,
StirmS.,
WirthM.1984; The carbohydrates of mouse hepatitis virus (MHV) A59: structures of the O-glycosidically linked oligosaccharides of glycoprotein E1. EMBO J 3:665–670
OpsteltenD. J.,
de GrooteP.,
HorzinekM. C.,
VennemaH.,
RottierP. J.1993; Disulfide bonds in folding and transport of mouse hepatitis coronavirus glycoproteins. J Virol 67:7394–7401
PeirisJ. S.,
LaiS. T.,
PoonL. L. 14 other authors; 2003; Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361:1319–1325[CrossRef]
RaamsmanM. J.,
LockerJ. K.,
de HoogeA.,
de VriesA. A.,
GriffithsG.,
VennemaH.,
RottierP. J.2000; Characterization of the coronavirus mouse hepatitis virus strain A59 small membrane protein E. J Virol 74:2333–2342[CrossRef]
SimmonsG.,
ReevesJ. D.,
RennekampA. J.,
AmbergS. M.,
PieferA. J.,
BatesP.2004; Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc Natl Acad Sci U S A 101:4240–4245[CrossRef]
SternD. F.,
SeftonB. M.1982; Coronavirus proteins: structure and function of the oligosaccharides of the avian infectious bronchitis virus glycoproteins. J Virol 44:804–812
SuiJ.,
LiW.,
MurakamiA.11 other authors2004; Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. Proc Natl Acad Sci U S A 101:2536–2541[CrossRef]
TaguchiF.,
IkedaT.,
SaekiK.,
KuboH.,
KikuchiT.1993; Fusogenic properties of uncleaved spike protein of murine coronavirus JHMV. Adv Exp Med Biol 342:171–175
TripetB.,
HowardM. W.,
JoblingM.,
HolmesR. K.,
HolmesK. V.,
HodgesR. S.2004; Structural characterization of the SARS-coronavirus spike S fusion protein core. J Biol Chem 279:20836–20849[CrossRef]
TsangK. W.,
HoP. L.,
OoiG. C.13 other authors2003; A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med 348:1977–1985[CrossRef]
WangP.,
ChenJ.,
ZhengA.15 other authors2004; Expression cloning of functional receptor used by SARS coronavirus. Biochem Biophys Res Commun 315:439–444[CrossRef]
WilliamsR. K.,
JiangG. S.,
HolmesK. V.1991; Receptor for mouse hepatitis virus is a member of the carcinoembryonic antigen family of glycoproteins. Proc Natl Acad Sci U S A 88:5533–5536[CrossRef]
WongS. K.,
LiW.,
MooreM. J.,
ChoeH.,
FarzanM.2004; A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2. J Biol Chem 279:3197–3201
XiaoX.,
ChakrabortiS.,
DimitrovA. S.,
GramatikoffK.,
DimitrovD. S.2003; The SARS-CoV S glycoprotein: expression and functional characterization. Biochem Biophys Res Commun 312:1159–1164[CrossRef]
XiaoX.,
FengY.,
ChakrabortiS.,
DimitrovD. S.2004; Oligomerization of the SARS-CoV S glycoprotein: dimerization of the N-terminus and trimerization of the ectodomain. Biochem Biophys Res Commun 322:93–99[CrossRef]
YangT. T.,
ChengL.,
KainS. R.1996; Optimized codon usage and chromophore mutations provide enhanced sensitivity with the green fluorescent protein. Nucleic Acids Res 24:4592–4593[CrossRef]
YangZ. Y.,
KongW. P.,
HuangY.,
RobertsA.,
MurphyB. R.,
SubbaraoK.,
NabelG. J.2004a; A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature 428:561–564[CrossRef]
YangZ. Y.,
HuangY.,
GaneshL.,
LeungK.,
KongW. P.,
SchwartzO.,
SubbaraoK.,
NabelG. J.2004b; pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN. J Virol 78:5642–5650[CrossRef]
YeagerC. L.,
AshmunR. A.,
WilliamsR. K.,
CardellichioC. B.,
ShapiroL. H.,
LookA. T.,
HolmesK. V.1992; Human aminopeptidase N is a receptor for human coronavirus 229E. Nature 357:420–422[CrossRef]
YingW.,
HaoY.,
ZhangY.33 other authors2004; Proteomic analysis on structural proteins of severe acute respiratory syndrome coronavirus. Proteomics 4:492–504[CrossRef]